Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study to Calculate the Radiation-Absorbed Dose of Technetium-99m Macroaggregated Albumin (99mTc-MAA) to the Whole Body and Non-Liver Critical Organs

NCT05848947 is registered in ClinicalTrials.gov with Sirtex Medical as lead sponsor.

NCT NCT05848947
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05848947 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study to Calculate the Radiation-Absorbed Dose of Technetium-99m Macroaggregated Albumin (99mTc-MAA) to the Whole Body and Non-Liver Critical Organs
Lead sponsor
Sirtex Medical
Phase
Phase 4
Overall status
Completed
Start date
April 25, 2023
Completion date
July 5, 2023
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, carcinoma, hepatocellular, liver neoplasm